These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32577495)

  • 21. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.
    Dahal K; Rijal J; Panta R; Lee J; Azrin M; Lootens R
    Cardiovasc Revasc Med; 2014; 15(8):408-13. PubMed ID: 25454258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Bangalore S; Kumar S; Poddar KL; Ramasamy S; Rha SW; Faxon DP
    Am J Cardiol; 2011 May; 107(9):1300-10. PubMed ID: 21349487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete Revascularization in Patients With STEMI and Multi-Vessel Disease: A Meta-Analysis of Randomized Controlled Trials.
    Al-Abdouh A; Barbarawi M; Bizanti A; Abudaya I; Upadhrasta S; Elias H; Zhao D; Savji N; Lakshman H; Hasan R; Michos ED
    Cardiovasc Revasc Med; 2020 May; 21(5):684-691. PubMed ID: 32241726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Okuya Y; Gohil K; Moussa ID
    Catheter Cardiovasc Interv; 2022 Sep; 100(3):340-350. PubMed ID: 35789058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease.
    Hamza M; Mahmoud N; Elgendy IY
    J Interv Cardiol; 2016 Jun; 29(3):241-7. PubMed ID: 27245121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Front Cardiovasc Med; 2021; 8():695822. PubMed ID: 35071337
    [No Abstract]   [Full Text] [Related]  

  • 31. Complete versus culprit-only percutaneous coronary intervention in elderly patients with acute coronary syndrome and multivessel coronary artery disease: A systematic review and meta-analysis.
    Franco AJ; Krishna MM; Joseph M; Ezenna C; Bakir ZE; Sudo RYU; Wippel CW; Ismayl M; Goldsweig AM; Uthirapathy I
    Cardiovasc Revasc Med; 2024 Jun; ():. PubMed ID: 38849266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials.
    Pasceri V; Patti G; Pelliccia F; Gaudio C; Speciale G; Mehran R; Dangas GD
    JACC Cardiovasc Interv; 2018 May; 11(9):833-843. PubMed ID: 29747913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
    Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
    JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
    Wang LJ; Han S; Zhang XH; Jin YZ
    BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.
    Di Pasquale G; Filippini E; Pavesi PC; Tortorici G; Casella G; Sangiorgio P
    Intern Emerg Med; 2016 Jun; 11(4):499-506. PubMed ID: 26951188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials.
    Elgendy IY; Huo T; Mahmoud A; Bavry AA
    Int J Cardiol; 2015; 186():98-103. PubMed ID: 25814353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis.
    Hu MJ; Tan JS; Jiang WY; Gao XJ; Yang YJ
    Ther Adv Chronic Dis; 2022; 13():20406223221078088. PubMed ID: 35295615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Fukutomi M; Toriumi S; Ogoyama Y; Oba Y; Takahashi M; Funayama H; Kario K
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E262-E268. PubMed ID: 30244539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Song YJ; Shin HC; Yang JI; Lee HY; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Jang JS
    J Interv Cardiol; 2015 Feb; 28(1):1-13. PubMed ID: 25689544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.